Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The target population typically has better health than participants in health research studies, such as cancer screening trials (the "healthy volunteer" effect).
Read Full NewsA 2023 review reexamines Yalta through a medical lens, showing how Roosevelt’s deteriorating cardiovascular status may have been underestimated.
Management of cardiometabolic risk factors for cardiovascular-kidney-metabolic syndrome falls short, particularly for younger adults, who have the lowest treatment rates.
Starting statins is associated with a reduced risk for frailty in older adults, including those with prefrailty at baseline.
The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.
Investing time in upfront patient communication improves self-management, builds trust, and reduces the need for long-term clinic visits.
Extreme heat affects the heart, lungs, kidneys, and brain while increasing hospital admissions, preterm birth, and pressure on the healthcare system.
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)
1.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
2.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
The Life-Saving Powers of Anemia: How to Combat the Disease.
2.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
3.
Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients
4.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
5.
Understanding the HAS-BLED Score: What It Is and Why It Matters
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge